Scandinavian trial of Uncomplicated Aortic Dissection Therapy
SUNDAY-studiet er en randomiseret undersøgelse, der evaluerer, om tilføjelsen af TEVAR til standardbehandling forbedrer femårsoverlevelsen ved ukompliceret type-B aortadissektion. Sekundære udfald inkluderer dødelighed, neurologiske hændelser, livskvalitet, omkostninger og reinterventioner. Subgruppeanalyser vil vurdere behandlingens omfang.
Find information on upcoming meetings, conferences, and workshops relevant to the SUNDAY Trial and its participants.
Stay informed about opportunities for professional collaboration, presentation of new research findings, and networking with colleagues across the Nordic region and Europe.
We update this section regularly to ensure you don’t miss important dates in aortic research and treatment.
